GHRP-6 (10mg)

GHRP-6 (10mg) protocols focus on this synthetic growth hormone-releasing peptide that stimulates endogenous growth hormone (GH) secretion by acting on the ghrelin receptor (GHS-R1a). It is studied for its potential role in supporting muscle recovery, appetite stimulation, fat metabolism, and overall anabolic signaling. This guide outlines a subcutaneous administration approach optimized for the 10 mg vial format.

  • Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration
  • Typical dosing range: 100–300 mcg per dose (1–3 times daily, subcutaneous)
  • Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks

Concise summary of the subcutaneous regimen.

  • Goal: Support natural growth hormone release for recovery, muscle maintenance, and metabolic support
  • Schedule: 1–3 daily injections depending on protocol goals
  • Dose Range: 100–300 mcg per dose
  • Timing: Commonly used pre-meal or before sleep for GH pulse support

Suggested approach for the 10 mg vial format.

  • Start: 100 mcg once daily to assess tolerance
  • Target: 100–300 mcg per dose
  • Frequency: 1–3 times per day (subcutaneous)
  • Vial Duration: One 10 mg vial typically lasts 10–30 days, depending on dosing frequency
  • Timing:
    • Morning (fasted state)
    • Pre-meal (appetite stimulation effect)
    • Before sleep (natural GH pulse support)

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that binds to the ghrelin receptor (GHS-R1a) in the hypothalamus and pituitary gland. This interaction stimulates the release of growth hormone (GH) in a pulsatile manner, mimicking natural secretion patterns.

Unlike direct GH administration, GHRP-6 promotes endogenous production, which may preserve physiological feedback regulation. It also increases appetite through ghrelin-mimicking activity and may influence metabolic pathways related to fat utilization, muscle repair, and recovery processes. Preclinical and clinical research suggest synergistic effects when combined with other GHRH analogs.

Observations based on preclinical and early-stage research.

Potential Benefits:

  • May increase natural growth hormone secretion
  • May support muscle recovery and lean mass maintenance
  • May enhance appetite (useful in weight gain protocols)
  • May support fat metabolism and overall recovery

Possible Side Effects:

  • Increased hunger or appetite stimulation
  • Mild water retention
  • Temporary tingling or flushing
  • Injection-site irritation
  • Long-term safety data in healthy populations remains limited; investigational use only